Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?

Máté Krausz; Noriko Mitsuiki; Valeria Falcone; Johanna Komp; Sara Posadas-Cantera; Hanns-Martin Lorenz; Jiri Litzman; Daniel Wolff; Maria Kanariou; Anita Heinkele; Carsten Speckmann; Georg Häcker; Hartmut Hengel; Laura Gámez-Díaz; Bodo Grimbacher

doi:10.3389/fimmu.2023.1226814

Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?

Front Immunol. 2023 Jun 2:14:1226814. doi: 10.3389/fimmu.2023.1226814. eCollection 2023.

Authors

Máté Krausz^{1

2

3

4}, Noriko Mitsuiki², Valeria Falcone⁵, Johanna Komp⁶, Sara Posadas-Cantera^{1

2

6}, Hanns-Martin Lorenz⁷, Jiri Litzman⁸, Daniel Wolff⁹, Maria Kanariou¹⁰, Anita Heinkele¹¹, Carsten Speckmann^{1

2

12}, Georg Häcker⁶, Hartmut Hengel⁵, Laura Gámez-Díaz^{1

2}, Bodo Grimbacher^{1

2

3

13

14

15}

Affiliations

¹ Institute for Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
² Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
³ Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁴ Faculty of Biology, University of Freiburg, Freiburg, Germany.
⁵ Institute of Virology, University Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁶ Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁷ Division of Rheumatology, Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
⁸ Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno and Medical Faculty, Masaryk University, Brno, Czechia.
⁹ Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
¹⁰ Department of Immunology and Histocompatibility, Centre for Primary Immunodeficiencies, "Aghia Sophia" Children's Hospital, Athens, Greece.
¹¹ Center for Pediatric Rheumatology, Olgahospital, Stuttgart, Germany.
¹² Department of Pediatric Hematology and Oncology, Center for Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
¹³ DZIF - German Center for Infection Research, Satellite Center Freiburg, Freiburg, Germany.
¹⁴ CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
¹⁵ RESIST - Cluster of Excellence 2155 to Hannover Medical School, Satellite Center Freiburg, Freiburg, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1011646.].

Keywords: cytotoxic T-lymphocyte antigen 4 (CTLA-4); disease modifiers; immune dysregulation; immunodeficencies; inborn errors of immunity (IEI).

Publication types

Published Erratum

Grants and funding

This work was supported by the Deutsche Forsch-ungsgemeinschaft (DFG) IMPATH SFB1160/2_B5. BG receives support by the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984, and RESIST – EXC 2155 – Project ID 390874280); by the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD; and by the German Federal Ministry of Education and Research (BMBF) through a grant to the German Auto-Immunity Network (GAIN), grant code 01GM1910A. HH is funded by the Deutsche Forschungsgemeinschaft (DFG) through HE2526/9-1. MK is supported by the Deutsche Forschungsgemeinschaft (DFG) SFB1160_2 as clinician scientist associated to IMM-PACT-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.